Mary Jane Norman

Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.

Benita S. Katzenellenbogen, Kari Kendra, Mary Jane Norman et al. · PubMed · 1987 · 412 citations

Breast Oncology, Chemoprevention Strategy, Cell Proliferation +18

Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.

Benita S. Katzenellenbogen, Mary Jane Norman, Richard L. Eckert et al. · PubMed · 1984 · 279 citations

Breast Oncology, Hydroxy-tamoxifen Isomers, Pharmacotherapy +20

Multihormonal Regulation of the Progesterone Receptor in MCF-7 Human Breast Cancer Cells: Interrelationships among Insulin/Insulin-Like Growth Factor-I, Serum, and Estrogen*

BENITA S. KATZENELLENBOGEN, Mary Jane Norman · Endocrinology · 1990 · 188 citations

Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.

Robert Clarke, N. Brünner, Benita S. Katzenellenbogen et al. · Proceedings of the National Academy of Sciences · 1989 · 184 citations · Full text

Breast Oncology, Human Growth, Gynecology +17

Estrogenic affinity labels: synthesis, irreversible receptor binding, and bioactivity of aziridine-substituted hexestrol derivatives

Jeffery A. Zablocki, John A. Katzenellenbogen, Kathryn E. Carlson et al. · Journal of Medicinal Chemistry · 1987 · 29 citations